Skip to content

An intervention study of an Internet of Things respiratory rehabilitation system in patients with GOLD stage 3 chronic obstructive pulmonary disease

An intervention study of an Internet of Things respiratory rehabilitation system in patients with GOLD stage 3 chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081888
Enrollment
Unknown
Registered
2024-03-14
Start date
2023-04-20
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Intervention group:Internet of Things-based home respiratory muscle training, all participants needed to complete 30 IMT and 30 EMT iterations in different respiratory cycles, twice daily for twelve c
Control group:routine nursing care, including health education and telephone follow-up.

Sponsors

Xiamen Haicang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for COPD established by the Respiratory Disease Society of the Chinese Medical Association; (2) Meet the diagnostic criteria related to COPD in the Internal medicine seventh edition; (3) Patients diagnosed with COPD per the Global Initiative for Chronic Obstructive Lung Disease criteria; (4) Voluntarily enroll in the program and be able to walk.

Exclusion criteria

Exclusion criteria: (1) Comorbidities such as cardiovascular disease, rheumatism, exercise hypertension, neuromuscular disease, and other conditions such as severe cognitive and psychiatric abnormalities that preclude the completion of rehabilitative exercises.

Design outcomes

Primary

MeasureTime frame
forced vital capacity;forced expiratory volume in one second;forced expiratory volume in one second/forced vital capacity;

Secondary

MeasureTime frame
maximal inspiratory pressure;maximal expiratory pressure;modified Medical Research Council dyspnea scale;COPD Assessment Test; the Hamilton Anxiety scale ; 6-month COPD-related re-admissions(emergencies were excluded);

Countries

China

Contacts

Public ContactXuejuan Wu

Xiamen Haicang Hospital

15060702657@163.com+86 150 6070 2657

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026